blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4119139

EP4119139 - MEDICAL USE OF ANYHDROICARITIN [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  16.12.2022
Database last updated on 19.10.2024
FormerThe international publication has been made
Status updated on  17.09.2021
Most recent event   Tooltip11.09.2024The date on which the examining division becomes responsible, has been established 
11.09.2024Amendment by applicant 
Applicant(s)For all designated states
Lunan Pharmaceutical Group Corporation
No.209, Hongqi Road
Linyi, Shandong 276006 / CN
[2023/03]
Inventor(s)01 / ZHANG, Guimin
No. 209 Hongqi Rd
Linyi, Shandong 276006 / CN
02 / YAO, Jingchun
No. 209 Hongqi Rd
Linyi, Shandong 276006 / CN
03 / SUN, Chenghong
No. 209 Hongqi Rd
Linyi, Shandong 276006 / CN
04 / LI, Bin
No. 209 Hongqi Rd
Linyi, Shandong 276006 / CN
05 / PAN, Sina
No. 209 Hongqi Rd
Linyi, Shandong 276006 / CN
 [2023/03]
Representative(s)Meissner Bolte Partnerschaft mbB
Patentanwälte Rechtsanwälte
Postfach 86 06 24
81633 München / DE
[N/P]
Former [2023/03]Held, Stephan
Meissner Bolte Patentanwälte
Rechtsanwälte Partnerschaft mbB
Widenmayerstraße 47
80538 München / DE
Application number, filing date21767587.509.03.2021
[2023/03]
WO2021CN79791
Priority number, dateCN20201016367610.03.2020         Original published format: CN202010163676
CN20201016367710.03.2020         Original published format: CN202010163677
CN20201016367210.03.2020         Original published format: CN202010163672
CN20201016367110.03.2020         Original published format: CN202010163671
CN20201016305510.03.2020         Original published format: CN202010163055
[2023/03]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021180087
Date:16.09.2021
Language:ZH
[2021/37]
Type: A1 Application with search report 
No.:EP4119139
Date:18.01.2023
Language:EN
[2023/03]
Search report(s)International search report - published on:CN16.09.2021
(Supplementary) European search report - dispatched on:EP20.02.2024
ClassificationIPC:A61K31/352, A61P7/04
[2023/03]
CPC:
A61P7/04 (EP,KR,US); A61K31/352 (EP,KR,US); A61K31/4365 (US);
A61K31/616 (US); A61K31/727 (US); A61K38/48 (US);
A61K38/482 (US); A61K38/49 (US); A61K47/10 (US);
A61K47/26 (US); A61K47/44 (US); A61K9/0019 (KR,US);
A61K9/1075 (KR,US); A61K9/20 (KR); A61K9/2018 (US);
A61K9/2031 (US); A61K9/2054 (US); A61K9/48 (KR);
A61K9/4825 (US); A61K9/4858 (US); A61K9/4866 (US);
A61K9/4875 (US); A61K9/4891 (US); A61P1/00 (US);
C12Y304/00 (US); C12Y304/21031 (US); C12Y304/21068 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/03]
TitleGerman:MEDIZINISCHE VERWENDUNG VON ANYHDROICARITIN[2023/03]
English:MEDICAL USE OF ANYHDROICARITIN[2023/03]
French:UTILISATION MÉDICALE DE L'ANYHDROICARITIN[2023/03]
Entry into regional phase10.10.2022Translation filed 
10.10.2022National basic fee paid 
10.10.2022Search fee paid 
10.10.2022Designation fee(s) paid 
10.10.2022Examination fee paid 
Examination procedure10.10.2022Examination requested  [2023/03]
11.09.2024Amendment by applicant (claims and/or description)
11.09.2024Date on which the examining division has become responsible
Fees paidRenewal fee
10.10.2022Renewal fee patent year 03
26.02.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]CN1460482  (UNIV ZHEJIANG [CN]);
 [A]CN103690524  (ZHOU YAWEI);
 [A]EP2808016  (BEIJING SHENOGEN PHARMA GROUP LTD [CN]);
 [X]CN104546823  (LUNAN PHARM GROUP CORP);
 [A]CN104546822  (LUNAN PHARM GROUP CORP);
 [A]CN105963293  (QINGDAO YUNTIAN BIOTECHNOLOGY CO LTD);
 [A]CN109369748  (GUANGDONG JINJUNKANG BIO TECH CO LTD);
by applicantUS6399579
 CN101637467
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.